Active, not recruitingPhase 2NCT03197506

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mayo Clinic
Principal Investigator
Ian F. Parney, MD, PhD
Mayo Clinic in Rochester
Intervention
External Beam Radiation Therapy(radiation)
Enrollment
52 enrolled
Eligibility
18 years · All sexes
Timeline
2018 – 2028

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03197506 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials